PD23-06 RADIOGRAPHIC PROGRESSION-FREE SURVIVAL AS A MEANINGFUL ENDPOINT IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC): THE TALAPRO-2 RANDOMIZED CLINICAL TRIAL | ReachRx